Outcome of Board Meeting

---- Valiant Organics Limited November 05, 2026 To, To, Listing / Compliance Department Listing / Compliance Department BSE LTD National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza, Plot No. C/1, Dalal Street G Block Bandra-Kurla Complex, Mumbai- 400 001 Bandra (E), Mumbai- 400 051. SCRIP CODE – 540145 SYMBOL- VALIANTORG Dear Sir / Madam, Sub: Outcome of the Board Meeting Ref: Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the “SEBI Listing Regulations”) Pursuant to Regulation 30 read with Paragraph A of Part A of Schedule III to the SEBI Listing Regulations, as amended, we wish to inform you that the Board of Directors of the Company, at its meeting held today, Thursday, November 5, 2026, considered and approved, the Unaudited Standalone and Consolidated Financial Results (“Financial Results”) for the quarter and half year ended September 30, 2026, as recommended by the Audit Committee. We enclose the following documents as Annexure A.: a) Statements of Unaudited Standalone and Consolidated Financial Results b) Limited Review Reports issued by the Statutory Auditors c) Statement of Asset and Liabilities d) Cash Flow Statements Further, please note that the Company has already made necessary arrangement to publish the Financial Results in the Newspapers as required under Regulation 47 of the SEBI Listing Regulations. The Meeting of the Board of Directors commenced at 03.07 P.M. (IST) and concluded at 5.00 P.M. (IST). Kindly take the same on your record. Thanking you, Yours faithfully, For Valiant Organics Limited Kaustubh Kulkarni Company Secretary ICSI M No. A52980 Encl.: a/a Regd. Office:109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Rd, Mulund (W), Mumbai 400 080, Maharashtra, India. Corporate Office: 701-A, 7th Floor, Tower-B, Embassy 247, L.B.S. Road, Vikhroli (W), Mumbai - 400 083, Maharashtra, India. +91 22 6797 6683 • info@valiantorganics.com • www.valiantorganics.com CIN NO.: L24230MH2005PLC151348 (Ar gokhale & sathe LLP ANNEXURE A chartered accountants IND IA (formerly known as gokhale & sathe) 304/308/309/311,udyog mandir no. I, 7-c, bhagoji keer marg,mahim, mumbai • 400 016,maharashtra,india. Independent Auditors' Limited Review Report on the Unaudited Standalone Financial Results of Valiant Organics Limited for the Quarter and Half Year Ended 30 September 2026, Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, as amended. The Board of Directors, Valiant Organics Limited. 1 We have reviewed the accompanying statement of unaudited standalone financial results ("the Statement") of Valiant Organics Limited ('the Company') for the quarter and half year ended 30 September 2026 being submitted by the Company pursuant to the requirement of Regulation 33 of SEBI (LODR) Regulation 2015 as amended ("Listing Regulations). 2 This Statement, which is the responsibility of the Company's management and approved by the Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 ("the Act") read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to issue a report on the Statement based on our review. 3 We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the Institute of Chartered Accountants of India. This Standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial results are free of material misstatement. A review of interim financial information consists of making inquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. 4 Based on our review conducted as above, nothing has come· to our attention that causes us to believe that the accompanying Statement, prepared in accordance with applicable Indian Accounting Standards specified under section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other recognised accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement. For Gokhale & Sathe LLP, Chartered Accountants, (Formerly known as Gokhale & Sathe), ICAI Firm Registration No.: 103264W/W101312 Ravindra More Partner ICAI Membership No.: 153666 UDIN: 26153666XSHLHR1178 Date: 05 November 2026 Place: Mumbai Tel.(off). : +91 022 4348 4242 I Email : office@gokhalesathe.in I Website : www.gokhalesathe.com ea.,,,,. Valiant Organics Lfmited Valiant organicu Addresss -109, Udyog Kshetra, 1st Floor, Mulund Goregaon Link Road, Mulund (W), Mumbai -400 080. Lirn1tocl CIN :-L24230MH2005PLC151348 ANNEXURE I Statement of Standalone Unaudited Financial Results for the Quarter and Half year ended 30th September,2026 Rs. In Lakhs (except EPS) Sr. No. Particulars Standalone Quarter Ended Half Year Ended Year Ended 30-Sept-2026 30-J une-2026 30-Sept-2025 30-Sept-2026 30-Sept-2025 31-Mar-2026 (Reviewed) (Reviewed) (Reviewed) (Reviewed) (Reviewed) (Audited) 1 Income a) Revenue from Operations 30,421.76 23,153.85 15,720.69 53,575.61 36,161.33 73,838.31 b) Other Income 110.66 264.20 19.50 374.86 126.92 691.48 Total Income 30,532.42 23,418.05 15,740.19 53,950.47 36,288.25 74,529.79 2 Expenses a) Cost of Materials consumed 18,870.70 15,032.08 9,604.13 33,902.78 22,150.08 44,126.75 b) Purchases of stock in Trade 53.33 20.25 4.61 73.58 18.96 193.64 c) Changes in inventories of Finished Goods, WlP & Stock-In-Trade 610.49 (1,678.97) (1,043.97) (1,068.48) {1,025.09) (62164) d) Employee benefit expenses 1,389.39 1,311.40 1,197.41 2,700.78 2,383.07 4,885.69 e) Finance Cost 518.16 512.93 425.63 1,031.09 1,030.20 1,819.91 f) Depreciation, Amortization and impairment Expense 1,031.13 1,021.97 978.19 2,053.11 1,919.89 3,956.50 g) Other exoenses 5,595.62 4,306.69 3,838.16 9,902.31 8,026.80 16,435.15 Total Expenses 28,068.81 20,526.35 15,004.15 48,595.16 34,503.90 70,795.98 3 Profit/(Lossl before exceotional item & tax ( 1-2) 2,463.61 2,891.70 736.04 5,355.31 1,784.35 3,733.81 4 Exceptional Items (Gain/ (Loss))(Refer Note No. 6) - - 572.08 5 Profil/ (Loss) before tax ( 3-4) 2,463.61 2,891.70 736.04 5,355.31 1,784.35 4,305.89 6 Tax expense (Net) a) Current Year Tax 476.00 476.00 b) Short/ (Excess) Provision for Tax of Previous Years (253.17) c) Deferred Tax 272.56 709.43 176.41 981.99 466.87 1,123.50 Total Tax expense (Net) 748.56 709.43 176.41 1,457.99 466.87 870.33 7 Net Profit/ ( Loss) for the period (5-6) 1,715.05 2,182.27 559.62 3,897.32 1,317.47 3,435.56 8 Other Comprehensive Income Item that will not to be reclassified to statement of Profit and Loss Remeasurement of defined benefit Liability/ Assets & Fair value changes on (45.67) 37.68 (48.51) (7.98) (11.32) 7.20 Inveshnents Taxes on Remeasurement of defined benefit Liability/ Assets & Fair value 17.12 (6.14) 7.25 10.98 3.00 (2.65) changes on lnvesbnents Total Other Comprehensive Income/ {Loss) (28.55) 31.54 (41.26) 3.00 (8.32) 4.55 9 Total of profit and other comprehensive income for the year ( 7+8) 1,686.50 2,213.81 518.36 3,900.31 1,309.15 3,440.11 10 Other Equity excluding revaluation reserve 66,883.14 11 Profit attributable to: Owners of the Comp [Showing first 8,000 characters — download PDF for full document]